Literature DB >> 31067395

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. Reply.

Stephen D Wiviott1, Itamar Raz2, Marc S Sabatine3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31067395     DOI: 10.1056/NEJMc1902837

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

1.  First experience with sodium-glucose co-transporter 2 inhibitors in Polish patients with cardiovascular diseases.

Authors:  Ewa Dziewięcka; Mateusz Winiarczyk; Matylda Gliniak; Monika Kaciczak; Sylwia Wiśniowska-Śmiałek; Aleksandra Karabinowska; Katarzyna Holcman; Magdalena Kostkiewicz; Marta Hlawaty; Agata Leśniak-Sobelga; Piotr Podolec; Paweł Rubiś
Journal:  Cardiol J       Date:  2020-08-13       Impact factor: 2.737

2.  Development and Validation of Prediction Models of Adverse Kidney Outcomes in the Population With and Without Diabetes.

Authors:  Morgan E Grams; Nigel J Brunskill; Shoshana H Ballew; Yingying Sang; Josef Coresh; Kunihiro Matsushita; Aditya Surapaneni; Samira Bell; Juan J Carrero; Gabriel Chodick; Marie Evans; Hiddo J L Heerspink; Lesley A Inker; Kunitoshi Iseki; Philip A Kalra; H Lester Kirchner; Brian J Lee; Adeera Levin; Rupert W Major; James Medcalf; Girish N Nadkarni; David M J Naimark; Ana C Ricardo; Simon Sawhney; Manish M Sood; Natalie Staplin; Nikita Stempniewicz; Benedicte Stengel; Keiichi Sumida; Jamie P Traynor; Jan van den Brand; Chi-Pang Wen; Mark Woodward; Jae Won Yang; Angela Yee-Moon Wang; Navdeep Tangri; John Chalmers; Mark Woodward; Chi-Yuan Hsu; Ana C Ricardo; Amanda Anderson; Panduranga Rao; Harold Feldman; Alex R Chang; Kevin Ho; Jamie Green; H Lester Kirchner; Samira Bell; Moneeza Siddiqui; Colin Palmer; Varda Shalev; Gabriel Chodick; Benedicte Stengel; Marie Metzger; Martin Flamant; Pascal Houillier; Jean-Philippe Haymann; Nikita Stempniewicz; John Cuddeback; Elizabeth Ciemins; Csaba P Kovesdy; Keiichi Sumida; Juan J Carrero; Marco Trevisan; Carl Gustaf Elinder; Björn Wettermark; Philip Kalra; Rajkumar Chinnadurai; James Tollitt; Darren Green; Josef Coresh; Shoshana H Ballew; Alex R Chang; Ron T Gansevoort; Morgan E Grams; Orlando Gutierrez; Tsuneo Konta; Anna Köttgen; Andrew S Levey; Kunihiro Matsushita; Kevan Polkinghorne; Elke Schäffner; Mark Woodward; Luxia Zhang; Shoshana H Ballew; Jingsha Chen; Josef Coresh; Morgan E Grams; Kunihiro Matsushita; Yingying Sang; Aditya Surapaneni; Mark Woodward
Journal:  Diabetes Care       Date:  2022-09-01       Impact factor: 17.152

Review 3.  Progress in the management of patients with diabetes and chronic kidney disease.

Authors:  Leonardo Pozo Garcia; Sandhya S Thomas; Harsith Rajesh; Sankar D Navaneethan
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-07-18       Impact factor: 3.416

Review 4.  Glucose-Lowering Therapy beyond Insulin in Type 1 Diabetes: A Narrative Review on Existing Evidence from Randomized Controlled Trials and Clinical Perspective.

Authors:  Felix Aberer; Thomas R Pieber; Max L Eckstein; Harald Sourij; Othmar Moser
Journal:  Pharmaceutics       Date:  2022-05-31       Impact factor: 6.525

5.  Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United States.

Authors:  Veer Sangha; Kasia Lipska; Zhenqiu Lin; Silvio E Inzucchi; Darren K McGuire; Harlan M Krumholz; Rohan Khera
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2021-11-15

Review 6.  Sodium-glucose Co-transporters-2 Inhibitors and Heart Failure: State of the Art Review and Future Potentials.

Authors:  Eri Toda Kato; Takeshi Kimura
Journal:  Int J Heart Fail       Date:  2020-01-13

7.  Empagliflozin in Heart Failure: Diuretic and Cardiorenal Effects.

Authors:  Matthew Griffin; Veena S Rao; Juan Ivey-Miranda; James Fleming; Devin Mahoney; Christopher Maulion; Nisha Suda; Krishmita Siwakoti; Tariq Ahmad; Daniel Jacoby; Ralph Riello; Lavanya Bellumkonda; Zachary Cox; Sean Collins; Sangchoon Jeon; Jeffrey M Turner; F Perry Wilson; Javed Butler; Silvio E Inzucchi; Jeffrey M Testani
Journal:  Circulation       Date:  2020-05-15       Impact factor: 29.690

Review 8.  The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk.

Authors:  Cyrielle Caussy; Adrien Aubin; Rohit Loomba
Journal:  Curr Diab Rep       Date:  2021-03-19       Impact factor: 4.810

Review 9.  Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing.

Authors:  Stephen C Cunnane; Mark J Millan; Eugenia Trushina; Cecilie Morland; Alessandro Prigione; Gemma Casadesus; Zane B Andrews; M Flint Beal; Linda H Bergersen; Roberta D Brinton; Suzanne de la Monte; Anne Eckert; Jenni Harvey; Ross Jeggo; Jack H Jhamandas; Oliver Kann; Clothide Mannoury la Cour; William F Martin; Gilles Mithieux; Paula I Moreira; Michael P Murphy; Klaus-Armin Nave; Tal Nuriel; Stéphane H R Oliet; Frédéric Saudou; Mark P Mattson; Russell H Swerdlow
Journal:  Nat Rev Drug Discov       Date:  2020-07-24       Impact factor: 84.694

10.  Efficacy and safety of dual add-on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52-week, randomized, active-controlled trial.

Authors:  Juan P Frias; Guillermo Gonzalez-Galvez; Eva Johnsson; Jill Maaske; Marcia A Testa; Donald C Simonson; Nalina Dronamraju; Ricardo Garcia-Sanchez; Anne L Peters
Journal:  Diabetes Obes Metab       Date:  2020-03-09       Impact factor: 6.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.